Expanding the reach of antibody therapeutics
Determined to revolutionize the reach of cancer treatment by developing potent and precise therapies that can target the entire universe of cancer antigens
Why Crossbow

We aim to cure cancer. Our team is urgently working to create an arsenal of therapeutics that expands the reach and impact of antibodies used to treat cancer.
We chose the name Crossbow because our next-generation therapies embody the precision and power of a crossbow. With unparalleled accuracy and potency, our T-Bolt molecules strike tumor cells like a crossbow shoots bolts at its target.
Join us on our bold quest to broaden the benefits of immunotherapy and improve the lives of people living with cancer.
TM
What we do

Who we are
A team of international, collaborative and experienced inventors, drug developers and company builders. We value scientific excellence, passion, integrity, innovation, transparency, respect and accountability. We embrace problems deemed impossible to solve.
News & Media
Keep up to date with everything happening at Crossbow
July 11, 2023
Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance
a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer



